Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1128|38|2|381-425

ISSN： 0198-6325

Source： MEDICINAL RESEARCH REVIEWS, Vol.38, Iss.2, 2018-03, pp. : 381-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Free Fatty Acid Particles in Protein Formulations, Part 1: Microspectroscopic Identification

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 2, 2015-02 ,pp. : 433-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

1D Copper Nanostructures: Progress, Challenges and Opportunities

By  

SMALL, Vol. 11, Iss. 11, 2015-03 ,pp. : 1232-1252

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel Microdevice for Rapid Neutrophil Purification and Phenotyping in Type 2 Diabetes Mellitus

By  

SMALL, Vol. 14, Iss. 6, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synthesis and Evaluation of a Series of Long‐Acting Glucagon‐Like Peptide‐1 (GLP‐1) Pentasaccharide Conjugates for the Treatment of Type 2 Diabetes

By  

CHEMMEDCHEM, Vol. 10, Iss. 8, 2015-08 ,pp. : 1424-1434

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of rheograms of the blood of patients with myocardial ischemia and type-2 diabetes mellitus with the use of a new model in the process of pharmaceutical therapy

By Yamaikina I.   Tagkhizadekh G.   Mit’kovskaya N.  

Journal of Engineering Physics and Thermophysics, Vol. 78, Iss. 5, 2005-09 ,pp. : 1029-1033

Springer Publishing Company

Access to resources Recommend Favorite